Enhancement of Manufacturing Technology for Finished Dosage Form of Bivalent Chemical Tableted Cholera Vaccine
Objective of the study is to experimentally substantiate the possibility to improve manufacturing efficiency by means of mass reduction of a vaccine tablet from 300 to 100 mg. Materials and methods. Inaba O-antigen lyophilizate serves as the specific immunogenic component of the vaccine. Results and...
Saved in:
Main Authors: | A. V. Komissarov, A. Yu. Ul’Yanov, O. A. Volokh, I. V. Shul’Gina, O. A. Lobovikova, O. D. Klokova, A. K. Nikiforov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2016-03-01
|
Series: | Проблемы особо опасных инфекций |
Subjects: | |
Online Access: | https://journal.microbe.ru/jour/article/view/294 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Studies of Freeze-Drying of Cholera Chemical Vaccine Immunogens
by: A. V. Komissarov, et al.
Published: (2016-03-01) -
Hardware-Controlled Method of Desalting Antigen Components of Cholera Chemical Vaccine
by: A. V. Komissarov, et al.
Published: (2014-12-01) -
Strategies for Abatement of Contamination of Tableted Live Plague Vaccine at Different Stages of Manufacturing
by: A. S. Tumanov, et al.
Published: (2016-03-01) -
Phosphatase Activity in Chemical Cholera Vaccine and its Components
by: O. V. Gromova, et al.
Published: (2012-06-01) -
Relevant issues of testing quality of drugs in the form of tablets
by: E. L. Kovaleva, et al.
Published: (2018-02-01)